FIG 7.
Protective effect of WYBQ-4 on systemic infection induced by MRSA USA300 and clinically isolated MRSA strains in mice. (A) Experimental protocol for a mouse systemic infection model. (B to D) Protective effects of WYBQ-4, cefepime, and moxalactam against systemic infection induced by (B) MRSA USA300 and clinical isolates of MRSA strains, (C) SA28, and (D) SA1B2B in mice.
